Changing healthcare is hard. Communicating it shouldn't be.

I'm Crystal Olivas-Rasmussen, PhD, a biochemist and medical writer. I help pharma and biotech teams, and the healthcare creatives who work with them, turn complex science into clear, accurate, review-ready communication.

For med comms & pharma teams

Congress and publication materials

One study, told three ways: a congress abstract, a slide deck, and a plain language summary built from the same clinical data. Plus a poster and a conference talk from my own research.

Abstract

Sildenafil congress abstract

Structured results within a strict word limit, with every number traceable to the data.

Read the abstract →
Slide deck

Sildenafil slide deck

Clinical data organized into a clear story for an HCP audience.

View the slides →
Plain language summary

Sildenafil plain language summary

The same study rewritten for patients and the public, at an everyday reading level.

Read the summary →
Scientific posterSRBR 2026
Thumbnail of the Nocturnin mitochondrial fragmentation poster

Nocturnin-mediated mitochondrial fragmentation

Original research designed for a busy poster hall: one clear message per panel.

View the poster →
Conference talkGRS 2025

Elucidating the enzymatic mechanism of Nocturnin and development of pharmacological inhibitors

An invited oral presentation of mechanism and drug discovery data at a Gordon Research Seminar.

Gordon Research Seminar · July 2025

Slides available on request

For ad agencies & copywriters

MLR review and promotional accuracy

Persuasive copy still has to survive medical, legal, and regulatory review. These samples show how I connect each claim to its source and catch problems before reviewers do.

MLR claim reviewNew

Claim substantiation review of an Ozempic® HCP page

Six claims checked against the prescribing information and trial papers, with fair-balance and trademark flags.

Independent practice exercise · October 2026

Read the review →
Promotional copyNew

Annotated HCP web copy for a PKU medicine

Promotional claims pinned to their exact sources, plus the overreach a reviewer would catch.

Fictional product · illustrative data

See the annotated copy →
For biotech founders

Grants and investor materials

Early-stage teams need non-dilutive funding and clear scientific stories for investors. I write both, working directly from your data.

NIH SBIR Specific AimsNew

Oral chaperones to restore PAH activity in phenylketonuria

A one-page Specific Aims with a clear gap, testable hypothesis, and go/no-go milestones.

Fictional company · illustrative data

Read the Specific Aims →
Investor one-pagerNew

Resetting the body clock for people who work at night

A non-confidential summary that makes circadian biology clear to investors without a science background.

Fictional company · illustrative data

Read the one-pager →
Peer-reviewed & public writing

Published research and science writing

Peer-reviewed research spanning circadian biology and the phenylketonuria enzyme, plus science written for a general audience. Earlier papers are published under Crystal A. Khan.

First-author articleOpen access

Evolutionary divergence of Nocturnin led to redox regulation in mammalian orthologs

Biochemistry and Biophysics Reports · 2026

Read the article ↗
First-author article

Characterization of the enzymatic activity of the rhythmic human NADP(H) phosphatase, Nocturnin

Archives of Biochemistry and Biophysics · 2026

Read the article ↗
First-author article

The phenylketonuria-associated substitution R68S converts phenylalanine hydroxylase to a constitutively active enzyme but reduces its stability

Journal of Biological Chemistry · 2019 · as Crystal A. Khan

Read the article ↗
Co-author article

Thermal profiling reveals phenylalanine hydroxylase as an off-target of panobinostat

Nature Chemical Biology · 2016 · as Crystal A. Khan

Read the article ↗
Science article for the public

Fall forward, spring back: the outdated and dangerous tradition of Daylight Saving Time

The Petri Dish · Summer 2026

Read the article →
About

I hold a PhD in Biochemistry and Biophysics and spent 15 years in academic research at UT Southwestern Medical Center before founding Olivas-Rasmussen Medical Writing LLC. My work has appeared in Nature Chemical Biology and Archives of Biochemistry and Biophysics.

I check every claim against its source, verify every number, and deliver on time.

Rare diseaseInborn errors of metabolismCircadian biologyEnzyme biochemistryRedox biology
What I write
  • Congress abstracts, posters, and slide decks
  • Manuscripts and publication support
  • Plain language summaries
  • Scientific QC and reference checking for MLR review
  • Scientific partnership for healthcare copywriters
  • Grant writing, including NIH SBIR/STTR
  • Advisory board materials and meeting reports